St. James, NY, United States of America

Patrick Hearing

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: The State University of New York. Active years: 2005-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrick Hearing. Retrieved from https://idiyas.com/inventor/patrick-hearing

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • St. James, NY (US) (2005 - 2009)
  • Saint James, NY (US) (2019 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Hearing

Introduction

Patrick Hearing is a notable inventor based in St. James, NY (US). He has made significant contributions to the field of gene therapy and biotechnology. With a total of 5 patents to his name, his work focuses on adeno-associated virus (AAV) technologies.

Latest Patents

One of Patrick Hearing's latest patents involves the development of adeno-associated virus Rep sequences, vectors, and viruses. This invention provides AAV replication (Rep) sequences, which include nucleotide sequences encoding a chimeric protein. The encoded chimeric protein contains a wild type AAV Rep inhibitory amino acid sequence. Additionally, the nucleotide sequences may contain a scrambled and/or deoptimized polynucleotide sequence encoding the wild type AAV Rep inhibitory amino acid sequence. The invention also provides vectors, cells, and viruses that incorporate these sequences. Furthermore, methods for detecting portions of the AAV Rep inhibitory amino acid sequence are included, which can reduce replication and/or infection by viruses. The compositions and methods developed by Hearing are particularly useful for site-specific integration and expression of heterologous sequences by recombinant AAV vectors and virus particles. These innovations have applications in gene therapy and vaccine development.

Career Highlights

Patrick Hearing is affiliated with the State University of New York, where he continues to advance his research and innovations. His work has positioned him as a key figure in the biotechnology sector, particularly in the realm of viral vector development.

Collaborations

Some of his notable coworkers include Wadie F Bahou and Varsha Sitaraman. Their collaborative efforts contribute to the ongoing research and development in the field of gene therapy.

Conclusion

Patrick Hearing's innovative work in adeno-associated virus technologies has made a significant impact on gene therapy and biotechnology. His contributions continue to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…